Inventor · disambiguated record
David M. Stern
Also filed as: STERN DAVID · STERN DAVID M
47 granted patents·20 pending applications·1,875 citations·filing 1978–2012
99Inventor score
Top patents by PatentIndex Score
67 records- 0196US5552267ASolution for prolonged organ preservationUNIV COLUMBIA·Filed 1994·Granted Sep 3, 1996·234 cites·47 claims
- 0295US6825164B1Method to increase cerebral blood flow in amyloid angiopathyUNIV COLUMBIA·Filed 2000·Granted Nov 30, 2004·75 cites·9 claims
- 0395US5370989ASolution for prolonged organ preservationUNIV COLUMBIA·Filed 1994·Granted Dec 6, 1994·143 cites·43 claims
- 0495US4485673ATwo-wire level measuring instrumentDREXELBROOK ENG CO·Filed 1981·Granted Dec 4, 1984·79 cites·6 claims
- 0594US6677299B2Method to increase cerebral blood flow in amyloid angiopathyTRUSTEE OF COLUMBIA UNIVERSITY·Filed 2001·Granted Jan 13, 2004·68 cites·16 claims
- 0694US6670136B2Extracellular novel RAGE binding protein (EN-RAGE) and uses thereofUNIV COLUMBIA·Filed 2001·Granted Dec 30, 2003·54 cites·2 claims
- 0792US7258857B2Rage-related methods for treating inflammationUNIV COLUMBIA·Filed 2001·Granted Aug 21, 2007·42 cites·11 claims
- 0892US7125675B2Method for inhibiting tumor invasion or spreading in a subjectUNIV COLUMBIA·Filed 2001·Granted Oct 24, 2006·26 cites·7 claims
- 0992US6563015B1Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereofUNIV COLUMBIA·Filed 2000·Granted May 13, 2003·31 cites·4 claims
- 1091US7494972B2Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemiaUNIV COLUMBIA·Filed 2005·Granted Feb 24, 2009·15 cites·12 claims
- 1190US7026444B2Extracellular novel RAGE binding protein (EN-RAGE) and uses thereofUNIV COLUMBIA·Filed 2003·Granted Apr 11, 2006·27 cites·2 claims
- 1289US6315995B1Methods for treating an ischemic disorder and improving stroke outcomeUNIV COLUMBIA·Filed 1998·Granted Nov 13, 2001·89 cites·7 claims
- 1388US5049878ATwo-wire compensated level measuring instrumentDREXELBROOK ENG CO·Filed 1989·Granted Sep 17, 1991·52 cites·13 claims
- 1488US4235106ASystem and method for obtaining compensated level measurementsDREXELBROOK CONTROLS·Filed 1978·Granted Nov 25, 1980·43 cites·26 claims
- 1587US7732400B2Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injuryUNIV COLUMBIA·Filed 2007·Granted Jun 8, 2010·16 cites·4 claims
- 1687US6969704B1Methods for suppressing early growth response—1protein (Egr-1) to reduce vascular injury in a subjectUNIV COLUMBIA·Filed 2000·Granted Nov 29, 2005·49 cites·6 claims
- 1787US6316403B1Methods for treating an ischemic disorder and improving stroke outcomeUNIV COLUMBIA·Filed 1997·Granted Nov 13, 2001·91 cites·19 claims
- 1885US7101838B2Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproductsUNIV COLUMBIA·Filed 1997·Granted Sep 5, 2006·54 cites·9 claims
- 1985US6555651B2Ligand binding site of rage and uses thereofUNIV COLUMBIA·Filed 1997·Granted Apr 29, 2003·65 cites·4 claims
- 2083US6555340B1Nucleic acid encoding bovine extracellular rage binding protein (en-rage)UNIV COLUMBIA·Filed 1999·Granted Apr 29, 2003·41 cites·14 claims
- 2183US5839443AMethod for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulationUNIV COLUMBIA·Filed 1996·Granted Nov 24, 1998·60 cites·10 claims
- 2281US8124829B2Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereofSTERN DAVID M·Filed 2010·Granted Feb 28, 2012·3 cites·2 claims
- 2381US6790443B2Method for treating symptoms of diabetesUNIV COLUMBIA·Filed 1996·Granted Sep 14, 2004·37 cites·11 claims
- 2481US6734168B2Endothelial monocyte activating polypeptide II: a mediator which activates host responseUNIV COLUMBIA·Filed 2001·Granted May 11, 2004·11 cites·3 claims
- 2581US6268479B1Intracellular amyloid-beta peptide binding (ERAB) polypeptideUNIV COLUMBIA·Filed 1997·Granted Jul 31, 2001·32 cites·2 claims
- 2680US7919670B1Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereofUNIV COLUMBIA·Filed 2000·Granted Apr 5, 2011·4 cites·2 claims
- 2780US6465422B1Method for inhibiting tumor invasion or spreading in a subjectUNIV COLUMBIA·Filed 1998·Granted Oct 15, 2002·35 cites·6 claims
- 2880US5641867AAntibody which specifically binds to endothelial-monocyte activating polypeptide IIUNIV COLUMBIA·Filed 1993·Granted Jun 24, 1997·51 cites·4 claims
- 2979US7700085B2Method for treating symptoms of diabetesUNIV COLUMBIA·Filed 2004·Granted Apr 20, 2010·8 cites·10 claims
- 3079US5510779AError compensating instrument system with digital communicationsDREXELBROOK CONTROLS·Filed 1993·Granted Apr 23, 1996·58 cites·22 claims
- 3176US7081241B1Extracellular rage binding protein (EN-RAGE) and uses thereofUNIV COLUMBIA·Filed 1998·Granted Jul 25, 2006·29 cites·20 claims
- 3276US6391300B1Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulationUNIV COLUMBIA·Filed 1998·Granted May 21, 2002·40 cites·7 claims
- 3374US8128963B2Methods for treating ischemic disorders using carbon monoxidePINSKY DAVID J·Filed 2003·Granted Mar 6, 2012·8 cites·14 claims
- 3474US6891081B1Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereofUNIV COLUMBIA·Filed 2000·Granted May 10, 2005·14 cites·8 claims
- 3574US6753150B2Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rageUNIV COLUMBIA·Filed 1998·Granted Jun 22, 2004·30 cites·15 claims
- 3670US5426097ACalreticulin: a novel antithrombotic agentUNIV COLUMBIA·Filed 1993·Granted Jun 20, 1995·35 cites·19 claims
- 3768US6228837B1Endothelial monocyte activating polypeptide II: a mediator which activates host responseUNIV COLUMBIA·Filed 1994·Granted May 8, 2001·28 cites·31 claims
- 3866US5728705AMethod of inducing vasorelaxation to treat pulmonary hypertensionUNIV COLUMBIA·Filed 1993·Granted Mar 17, 1998·30 cites·17 claims
- 3965US2008214453A1Methods for treating inflammationUNIV COLUMBIA·Filed 2007·Application pending·0 cites
- 4064US6994974B1Intracellular amyloid-beta binding (ERAB) polypeptide-related assaysUNIV COLUMBIA·Filed 1999·Granted Feb 7, 2006·12 cites·5 claims
- 4163US8133866B2Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injurySTERN DAVID M·Filed 2010·Granted Mar 13, 2012·1 cites·8 claims
- 4263US8067371B2RAGE G82S-related methods and compositions for treating inflammatory disordersSCHMIDT ANN MARIE·Filed 2004·Granted Nov 29, 2011·0 cites·15 claims
- 4363US5968911AMethod of inducing vasorelaxation to treat pulmonary hypertensionUNIV COLUMBIA·Filed 1994·Granted Oct 19, 1999·26 cites·47 claims
- 4462US2009191210A1Method for inhibiting tumor invasion or spreading in a subjectUNIV COLUMBIA·Filed 2007·Application pending·0 cites
- 4558US7060870B1Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer's disease and uses thereofUNIV COLUMBIA·Filed 2000·Granted Jun 13, 2006·2 cites·4 claims
- 4658US2008274975A1Methods and Compositions for Inhibiting Abad/Abeta Protein InteractionUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 4758US2009228997A1Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereofSCHMIDT ANN MARIE·Filed 2007·Application pending·0 cites
- 4857US4851831ATwo-wire level measuring instrumentDREXELBROOK ENG CO·Filed 1984·Granted Jul 25, 1989·15 cites·9 claims
- 4957US2009028882A1Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereofUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 5056US2007167360A1Methods for treating multiple sclerosisYAN SHI D·Filed 2004·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David M. Stern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →